May 28, 2014
Daiichi Sankyo’s antiplatelet agent Efient 3.75 mg/5 mg Tablets (prasugrel HCl), which the company hopes to turn into one of its next flagships, reached the Japanese market on May 27. Originated by Daiichi Sankyo and Ube Industries, the made-in-Japan oral...read more